VEGF −2578A/−1154G/+405G haplotype was associated with marginally improved prognosis whereas haplotype −2578C/−1154G/+405G was significantly associated with adverse prognosis in HER2 positive breast cancer patients [88]. This evidence concerns the gene ERBB2 and breast cancer.